Endurant Capital Management’s Akari Therapeutics AKTX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2021
Q1
Sell
-10,328
Closed -$382K 61
2020
Q4
$382K Buy
+10,328
New +$382K 0.14% 50
2018
Q4
Sell
-8,180
Closed -$419K 53
2018
Q3
$419K Sell
8,180
-835
-9% -$42.8K 0.19% 67
2018
Q2
$352K Sell
9,015
-860
-9% -$33.6K 0.15% 59
2018
Q1
$359K Sell
9,875
-180
-2% -$6.54K 0.13% 68
2017
Q4
$871K Buy
+10,055
New +$871K 0.27% 62